Insiders Updates
Lexaria Bioscience Corp’s latest rating changes from various analysts
Lexaria Bioscience Corp’s recent filing unveils that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ...
A company insider recently sold 8,800,000 shares of Solventum Corp [SOLV]. Should You also Consider to Sale?
Solventum Corp’s recent filing unveils that its 10% Owner 3M CO unloaded Company’s shares for reported $646.36 million on Aug ...
H.C. Wainwright gives a Buy recommendation for Moleculin Biotech Inc (MBRX)
Moleculin Biotech Inc’s recent filing unveils that its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0 ...
The Benchmark Company upgrades Holley Inc (HLLY) rating to a Buy
Holley Inc’s recent filing unveils that its Director LOBEL DAVID S unloaded Company’s shares for reported $5.52 million on Sep ...
Recent Insider Activity Suggests Potential Gains for NuScale Power Corporation (SMR)
NuScale Power Corporation’s recent filing unveils that its Director FLUOR CORP unloaded Company’s shares for reported $33.39 million on Oct ...
Guidewire Software Inc [GWRE] Insider Activity: An Update for Investors
Guidewire Software Inc’s recent filing unveils that its Chief Executive Officer Rosenbaum Michael George unloaded Company’s shares for reported $0.36 ...
Understanding the Risks of Investing in Option Care Health Inc (OPCH)
Option Care Health Inc’s recent filing unveils that its Director Wright Norman L. acquired Company’s shares for reported $99976.0 on ...
Insider Sale Alert: Solaris Energy Infrastructure Inc [SEI] – Is it Time to sell?
Solaris Energy Infrastructure Inc’s recent filing unveils that its Director BURKE JAMES R unloaded Company’s shares for reported $0.15 million ...
Monitoring Denny’s Corp (DENN) after recent insider movements
Denny’s Corp’s recent filing unveils that its Jumana Capital Investments LLC acquired Company’s shares for reported $0.82 million on Oct ...
HALO (Halozyme Therapeutics Inc) may reap gains as insiders became active recently
Halozyme Therapeutics Inc’s recent filing unveils that its PRESIDENT AND CEO Torley Helen unloaded Company’s shares for reported $1.51 million ...
